Vertex continues to capitalize on its leadership in cystic fibrosis (CF) treatments, where its blockbuster drug Trikafta is ...

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted regulatory approval for a ...

US biotech company Vertex Pharmaceuticals (Nasdaq: VRTX) has received European Commission approval to extend the use of its ...

The first guideline on newborn screening for cystic fibrosis recommends comprehensive genetic testing to ensure timely ...

Cystic Fibrosis Ireland sees an increasingly complex picture of what it means to be an older person living with CF ...

Hirschsprung disease and meconium ileus can both cause a newborn to be unable to pass their first stool. Learn the different ...

Vertex Pharmaceuticals is diversifying from its cystic fibrosis dominance into pain and other markets. Check out our ...

Sound Pharmaceuticals is pleased to announce that it has been invited to present its R&D and financing goals at four upcoming ...

All states should adopt updated screening protocols so more newborns with cystic fibrosis can be diagnosed in the first weeks of life, when interventions can have the greatest benefit, according to ...

BETHESDA, Md. (April 2, 2025) — The Cystic Fibrosis Foundation issued the following statement in response to recent mass ...

Forty-thousand -- that's the number of children and adults in America with cystic fibrosis, or "C-F."It's a genetic disorder ...